Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BL7

Mycobacterium tuberculosis efpA parallel dimer

This is a non-PDB format compatible entry.
Summary for 9BL7
Entry DOI10.2210/pdb9bl7/pdb
EMDB information44651
DescriptorUncharacterized MFS-type transporter EfpA, (2S)-3-{[(R)-[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-2-{[(2E,9E,13E)-hexadeca-2,9,13-trienoyl]oxy}propyl (4E,9E,11Z,15E)-octadeca-4,9,11,15-tetraenoate (2 entities in total)
Functional Keywordstransporter, membrane protein
Biological sourceMycobacterium tuberculosis H37Rv
Total number of polymer chains2
Total formula weight136152.13
Authors
Khandelwal, N.K.,Gupta, M.,Stroud, R.M. (deposition date: 2024-04-29, release date: 2025-02-05, Last modification date: 2025-08-27)
Primary citationKhandelwal, N.K.,Gupta, M.,Gomez, J.E.,Barkho, S.,Guan, Z.,Eng, A.Y.,Kawate, T.,Balasubramani, S.G.,Sali, A.,Hung, D.T.,Stroud, R.M.
Structure and inhibition mechanisms of Mycobacterium tuberculosis essential transporter efflux protein A.
Nat Commun, 16:3139-3139, 2025
Cited by
PubMed Abstract: A broad chemical genetic screen in Mycobacterium tuberculosis (Mtb) identified compounds (BRD-8000.3 and BRD-9327) that inhibit the essential efflux pump EfpA. To understand the mechanisms of inhibition, we determined the structures of EfpA with these inhibitors bound at 2.7-3.4 Å resolution. Our structures reveal different mechanisms of inhibition by the two inhibitors. BRD-8000.3 binds in a tunnel contacting the lipid bilayer and extending toward the central cavity to displace the fatty acid chain of a lipid molecule bound in the apo structure, suggesting its blocking of an access route for a natural lipidic substrate. Meanwhile, BRD-9327 binds in the outer vestibule without complete blockade of the substrate path to the outside, suggesting its possible inhibition of the movement necessary for alternate access of the transporter. Our results show EfpA as a potential lipid transporter, explain the basis of the synergy of these inhibitors and their potential for combination anti-tuberculosis therapy.
PubMed: 40169593
DOI: 10.1038/s41467-025-58133-6
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.22 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon